Barbara Bastow

879 total citations
19 papers, 602 citations indexed

About

Barbara Bastow is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Barbara Bastow has authored 19 papers receiving a total of 602 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Infectious Diseases, 13 papers in Virology and 4 papers in Epidemiology. Recurrent topics in Barbara Bastow's work include HIV Research and Treatment (13 papers), HIV/AIDS Research and Interventions (13 papers) and HIV/AIDS drug development and treatment (12 papers). Barbara Bastow is often cited by papers focused on HIV Research and Treatment (13 papers), HIV/AIDS Research and Interventions (13 papers) and HIV/AIDS drug development and treatment (12 papers). Barbara Bastow collaborates with scholars based in United States, Canada and Philippines. Barbara Bastow's co-authors include Joseph J. Eron, Ronald J. Bosch, Daniel R. Kuritzkes, Timothy Wilkin, Catherine Godfrey, Robert W. Coombs, Ann C. Collier, Susan L. Koletar, Lu Zheng and Cara C. Wilson and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and The Journal of Infectious Diseases.

In The Last Decade

Barbara Bastow

19 papers receiving 589 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Barbara Bastow United States	12	405	359	171	160	86	19	602
Brian Gazzard United Kingdom	15	480 1.2×	337 0.9×	189 1.1×	223 1.4×	122 1.4×	37	797
Mervyn Tyrer United Kingdom	15	668 1.6×	496 1.4×	143 0.8×	227 1.4×	72 0.8×	27	820
Elżbieta Bąkowska Poland	8	313 0.8×	225 0.6×	199 1.2×	177 1.1×	25 0.3×	18	512
Antonia L. Moore United Kingdom	11	537 1.3×	362 1.0×	244 1.4×	166 1.0×	33 0.4×	17	742
P. Puglièse France	14	287 0.7×	147 0.4×	116 0.7×	177 1.1×	42 0.5×	32	489
MA Johnson United Kingdom	12	431 1.1×	189 0.5×	214 1.3×	249 1.6×	54 0.6×	13	585
P. de Truchis France	10	351 0.9×	251 0.7×	147 0.9×	201 1.3×	22 0.3×	20	589
Cristina Mussini Italy	11	336 0.8×	229 0.6×	112 0.7×	184 1.1×	19 0.2×	27	484
Frederikke F. Rönsholt Denmark	10	156 0.4×	123 0.3×	166 1.0×	134 0.8×	58 0.7×	24	411
F. Raffi France	6	316 0.8×	139 0.4×	304 1.8×	161 1.0×	53 0.6×	16	530

Countries citing papers authored by Barbara Bastow

Since Specialization

Citations

This map shows the geographic impact of Barbara Bastow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Bastow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Bastow more than expected).

Fields of papers citing papers by Barbara Bastow

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Bastow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Bastow. The network helps show where Barbara Bastow may publish in the future.

Co-authorship network of co-authors of Barbara Bastow

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Bastow. A scholar is included among the top collaborators of Barbara Bastow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Bastow. Barbara Bastow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Bosch, Ronald J., Rajesh T. Gandhi, Florin Vaida, et al.. (2020). Continued Slow Decay of the Residual Plasma Viremia Level in HIV-1 – Infected Adults Receiving Long-term Antiretroviral Therapy. UNC Libraries. 2 indexed citations

Wilkin, Timothy, Huichao Chen, Michelle Cespedes, et al.. (2018). A Randomized, Placebo-Controlled Trial of the Quadrivalent Human Papillomavirus Vaccine in Human Immunodeficiency Virus-Infected Adults Aged 27 Years or Older: AIDS Clinical Trials Group Protocol A5298. Clinical Infectious Diseases. 67(9). 1339–1346. 94 indexed citations

Cranston, Ross, Michelle Cespedes, Ming Yang, et al.. (2017). High Baseline Anal Human Papillomavirus and Abnormal Anal Cytology in a Phase 3 Trial of the Quadrivalent Human Papillomavirus Vaccine in Human Immunodeficiency Virus–Infected Individuals Older Than 26 Years: ACTG 5298. Sexually Transmitted Diseases. 45(4). 266–271. 17 indexed citations

Riddler, Sharon A., Evgenia Aga, Ronald J. Bosch, et al.. (2015). Continued Slow Decay of the Residual Plasma Viremia Level in HIV-1–Infected Adults Receiving Long-term Antiretroviral Therapy. The Journal of Infectious Diseases. 213(4). 556–560. 37 indexed citations

Sha, Beverly E., Camlin Tierney, Xin Sun, et al.. (2015). PHARMACOKINETIC EXPOSURE AND VIROLOGIC RESPONSE IN HIV-1 INFECTED PREGNANT WOMEN TREATED WITH LOPINAVIR/RITONAVIR: AIDS CLINICAL TRIALS GROUP PROTOCOL A5153S: A SUBSTUDY TO A5150.. PubMed. 1(1). 4 indexed citations

McKinnon, John E., Robbie B. Mailliard, Susan Swindells, et al.. (2014). Baseline Natural Killer and T Cell Populations Correlation with Virologic Outcome after Regimen Simplification to Atazanavir/Ritonavir Alone (ACTG 5201). PLoS ONE. 9(5). e95524–e95524. 1 indexed citations

Harrison, Taylor, Sachiko Miyahara, Anthony Lee, et al.. (2013). Experience and Challenges Presented by a Multicenter Crossover Study of Combination Analgesic Therapy for the Treatment of Painful HIV-Associated Polyneuropathies. Pain Medicine. 14(7). 1039–1047. 22 indexed citations

Gandhi, Rajesh T., Ronald J. Bosch, Evgenia Aga, et al.. (2013). Residual Plasma Viraemia and Infectious HIV-1 Recovery from Resting Memory CD4 Cells in Patients on Antiretroviral Therapy: Results from ACTG A5173. Antiviral Therapy. 18(4). 1–7. 8 indexed citations

Sha, Beverly E., Camlin Tierney, Susan E. Cohn, et al.. (2011). Postpartum Viral Load Rebound in HIV-1–Infected Women Treated with Highly Active Antiretroviral Therapy: AIDS Clinical Trials Group Protocol A5150. HIV Clinical Trials. 12(1). 9–23. 31 indexed citations

10.

Taiwo, Babafemi, Lu Zheng, Sébastien Gallien, et al.. (2011). Efficacy of a nucleoside-sparing regimen of darunavir/ritonavir plus raltegravir in treatment-naive HIV-1-infected patients (ACTG A5262). AIDS. 25(17). 2113–2122. 113 indexed citations

11.

Shikuma, Cecilia M., Heather J. Ribaudo, Yu Zheng, et al.. (2010). Change in High-Sensitivity C-Reactive Protein Levels Following Initiation of Efavirenz-Based Antiretroviral Regimens in HIV-Infected Individuals. AIDS Research and Human Retroviruses. 27(5). 461–468. 26 indexed citations

12.

Tenorio, Allan R., Hongyu Jiang, Yu Zheng, et al.. (2009). Delaying a Treatment Switch in Antiretroviral-Treated HIV Type 1-Infected Patients with Detectable Drug-Resistant Viremia Does Not Have a Profound Effect on Immune Parameters: AIDS Clinical Trials Group Study A5115. AIDS Research and Human Retroviruses. 25(2). 135–139. 2 indexed citations

13.

Wilkin, Timothy, John E. McKinnon, A. Gregory DiRienzo, et al.. (2009). Regimen Simplification to Atazanavir‐Ritonavir Alone as Maintenance Antiretroviral Therapy: Final 48‐Week Clinical and Virologic Outcomes. The Journal of Infectious Diseases. 199(6). 866–871. 44 indexed citations

14.

Gandhi, Rajesh T., Ronald J. Bosch, Evgenia Aga, et al.. (2009). No Evidence for Decay of the Latent Reservoir in HIV‐1–Infected Patients Receiving Intensive Enfuvirtide‐Containing Antiretroviral Therapy. The Journal of Infectious Diseases. 201(2). 293–296. 59 indexed citations

15.

Eron, Joseph J., Jeong-Gun Park, Richard Haubrich, et al.. (2009). Predictive Value of Pharmacokinetics-Adjusted Phenotypic Susceptibility on Response to Ritonavir-Enhanced Protease Inhibitors (PIs) in Human Immunodeficiency Virus-Infected Subjects Failing Prior PI Therapy. Antimicrobial Agents and Chemotherapy. 53(6). 2335–2341. 7 indexed citations

16.

Demeter, Lisa M., Robin DiFrancesco, Hongyu Jiang, et al.. (2008). The Design and Implementation of A5146, a Prospective Trial Assessing the Utility of Therapeutic Drug Monitoring Using an Inhibitory Quotient in Antiretroviral-Experienced HIV-Infected Patients. HIV Clinical Trials. 9(1). 61–72. 5 indexed citations

17.

Smurzynski, Marlene, Ann C. Collier, Susan L. Koletar, et al.. (2008). AIDS Clinical Trials Group Longitudinal Linked Randomized Trials (ALLRT): Rationale, Design, and Baseline Characteristics. HIV Clinical Trials. 9(4). 269–282. 72 indexed citations

18.

Shikuma, Cecilia M., Marshall J. Glesby, William A. Meyer, et al.. (2007). Metabolic Effects of Protease Inhibitor-Sparing Antiretroviral Regimens Given as Initial Treatment of HIV-1 Infection (AIDS Clinical Trials Group Study A5095). JAIDS Journal of Acquired Immune Deficiency Syndromes. 44(5). 540–550. 42 indexed citations

19.

Riddler, Sharon A., Hongyu Jiang, Allan R. Tenorio, et al.. (2007). A Randomized Study of Antiviral Medication Switch at Lower-Versus Higher-Switch Thresholds: AIDS Clinical Trials Group Study A5115. Antiviral Therapy. 12(4). 531–541. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact